The prognostic impact of bleeding in STEMI patients treated by primary PCI depends on Killip class at presentation. S. Cornara1, A. Somaschini1, S. De Servi2, ...
Complications after cardiac interventions
P1066 | BEDSIDE The prevalence of non-access bleeding and its impact on short-term clinical outcomes in patients treated with percutaneous coronary intervention
without bleeding events. Bleeding had no effect on 30 day and 1-year mortality in patients presenting Killip class 1 (panel B of the Figure).
R. Fukuoka 1 , T. Kohno 1 , S. Kohsaka 1 , I. Ueda 1 , Y. Numasawa 2 , S. Noma 3 , M. Suzuki 4 , K. Hayashida 1 , S. Yuasa 1 , Y. Maekawa 1 , K. Fukuda 1 . 1 Keio University School of Medicine, Department of Cardiology, Tokyo, Japan; 2 Ashikaga Red Cross Hospital, Department of Cardiology, Tochigi, Japan; 3 Saiseikai Utsunomiya Hospital, Department of Cardiology, Tochigi, Japan; 4 National Hospital Organization, Saitama National Hospital, Department of Cardiology, Saitama, Japan Background: Bleeding is associated with increased risk of mortality and morbidity in patients treated with percutaneous coronary intervention (PCI). However, whether the bleeding originates from the arterial access site or the non-access organ system, has not been clearly discriminated in previous studies. They differ greatly in terms of their pathogenesis and management. Hence, we evaluated the prevalences of access site and non-access site bleedings in contemporary multicenter PCI registry, and aimed to clarify their clinical determinants and impact on short-term mortality. Methods and results: From 12281 consecutive patients who underwent PCI procedures from January 2010 to December 2013 at 15 Japanese hospitals participating JCD-KiCS Registry, which is an ongoing multicenter PCI database, we abstracted 357 patients who complicated the bleeding related to PCI. (age, 71.0±10.7 years; male, 66.0%; body mass index [BMI], 23.4±4.0 kg/m2 ). Access site bleeding occurred in 165 patients (1.3%) and non-access site bleeding in 192 (1.6%; gastrointestinal [n=40], urinary system [n=11], intracranial [n=7] and other or unknown location bleeding [n=141]). Multivariate analysis demonstrated that patients present with acute coronary syndrome (ACS) (β=3.05, 95% conﬁdence interval [CI] 1.72–5.39, p